On May 19, 2025, Elicio Therapeutics, Inc. held its Annual Meeting where stockholders voted to elect two directors and ratified the appointment of the independent accounting firm for the 2025 fiscal year. A total of 11,172,771 shares, or 70.1% of shares entitled to vote, participated in the meeting, with all proposals successfully adopted.